Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma PR Newswire...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or...
Kigali city, as seen from the north Kigali city, as seen from the north The Rwanda FDA has given regulatory approval to GreenLight...
Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea Canada NewsWire VANCOUVER, BC, Feb. 1, 2023 Clinical...
Dr. Lauren R. Natbony to be Principal InvestigatorVancouver, British Columbia--(Newsfile Corp. - January 26, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB:...
VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS Canada NewsWire MONTREAL, Jan....
Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with...
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American...
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease PR Newswire WATERTOWN, Mass. and TOKYO, Jan. 9, 2023 Next-generation IgG protease...
Calgary, AB – TheNewswire - January 4, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with...